Neuroptika Completes Enrollment in Phase 2 Clinical Trial for Dry Eye Disease
Neuroptika Completes Enrollment in Phase 2 Clinical Trial for Dry Eye Disease
top of page
NEUROPTIKA NEWS
- Jan 16, 2020
- 2 min
Neuroptika Announces Enrollment of First Patient In Phase 2 Clinical Trial for Dry Eye Disease
CAMBRIDGE, MA, January 16, 2019 – Neuroptika, a privately held biotechnology company focused on the development of novel regenerative...
bottom of page